FDA Cautions Cardiovascular Disease Patients About Risks of Chantix

by Savitha C Muppala on  June 17, 2011 at 10:30 PM Heart Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

The FDA has issued a warning to smokers who have a history of heart attack or stroke and who are on the smoking cessation drug varenicline (Chantix), about the risk of a second heart attack.
 FDA Cautions Cardiovascular Disease Patients About Risks of Chantix
FDA Cautions Cardiovascular Disease Patients About Risks of Chantix

The agency has confirmed that the drug's label will now carry this updated warning informing consumers about these risks.

The label will also carry a warning about varenicline, which may elevate the risk of peripheral vascular disease in victims of cardiovascular disease.

The FDA in  a statement has reaffirmed that it will continue to measure the  cardiovascular safety of Chantix and had  asked the manufacturer of the drug to conduct an analysis of data from all varenicline studies to understand the safety of using this drug.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Malnutrition to Obesity - The Big Leap 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...